The global Chronic Obstructive Pulmonary Disease (COPD) Treatment market was valued at US$ 12890 million in 2023 and is anticipated to reach US$ 16110 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Chronic Obstructive Pulmonary Disease (COPD) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Obstructive Pulmonary Disease (COPD) Treatment.

Report Scope

The Chronic Obstructive Pulmonary Disease (COPD) Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Obstructive Pulmonary Disease (COPD) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chronic Obstructive Pulmonary Disease (COPD) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report

Report Metric	Details
Report Name	Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
Accounted market size in 2023	US$ 12890 million
Forecasted market size in 2030	US$ 16110 million
CAGR	2.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Corticosteroids Phosphodiesterase Type 4 Inhibitors Bronchodilators Others
Segment by Application	Hospital Clinic Retail Pharmacies Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Boehringer Ingelheim International GmbH, GlaxoSmithKline, Novartis AG, Teva Pharmaceutical Industries, Sunovion Pharmaceuticals, CHIESI Farmaceutici, Orion Corporation, Mylan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Obstructive Pulmonary Disease (COPD) Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Chronic Obstructive Pulmonary Disease (COPD) Treatment Market growing?

Ans: The Chronic Obstructive Pulmonary Disease (COPD) Treatment Market witnessing a CAGR of 2.8% during the forecast period 2024-2030.

What is the Chronic Obstructive Pulmonary Disease (COPD) Treatment Market size in 2030?

Ans: The Chronic Obstructive Pulmonary Disease (COPD) Treatment Market size in 2030 will be US$ 16110 million.

Who are the main players in the Chronic Obstructive Pulmonary Disease (COPD) Treatment Market report?

Ans: The main players in the Chronic Obstructive Pulmonary Disease (COPD) Treatment Market are AstraZeneca, Boehringer Ingelheim International GmbH, GlaxoSmithKline, Novartis AG, Teva Pharmaceutical Industries, Sunovion Pharmaceuticals, CHIESI Farmaceutici, Orion Corporation, Mylan

What are the Application segmentation covered in the Chronic Obstructive Pulmonary Disease (COPD) Treatment Market report?

Ans: The Applications covered in the Chronic Obstructive Pulmonary Disease (COPD) Treatment Market report are Hospital, Clinic, Retail Pharmacies, Other

What are the Type segmentation covered in the Chronic Obstructive Pulmonary Disease (COPD) Treatment Market report?

Ans: The Types covered in the Chronic Obstructive Pulmonary Disease (COPD) Treatment Market report are Corticosteroids, Phosphodiesterase Type 4 Inhibitors, Bronchodilators, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Corticosteroids

1.2.3 Phosphodiesterase Type 4 Inhibitors

1.2.4 Bronchodilators

1.2.5 Others

1.3 Market by Application

1.3.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Retail Pharmacies

1.3.5 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Perspective (2019-2030)

2.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Growth Trends by Region

2.2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Historic Market Size by Region (2019-2024)

2.2.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Region (2025-2030)

2.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Dynamics

2.3.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Industry Trends

2.3.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Drivers

2.3.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Challenges

2.3.4 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment Players by Revenue

3.1.1 Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment Players by Revenue (2019-2024)

3.1.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue

3.4 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Concentration Ratio

3.4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue in 2023

3.5 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players Head office and Area Served

3.6 Key Players Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Solution and Service

3.7 Date of Enter into Chronic Obstructive Pulmonary Disease (COPD) Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Obstructive Pulmonary Disease (COPD) Treatment Breakdown Data by Type

4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Historic Market Size by Type (2019-2024)

4.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Type (2025-2030)

5 Chronic Obstructive Pulmonary Disease (COPD) Treatment Breakdown Data by Application

5.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Historic Market Size by Application (2019-2024)

5.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2019-2030)

6.2 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2019-2024)

6.4 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2019-2030)

7.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2019-2024)

7.4 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2019-2030)

8.2 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2019-2030)

9.2 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2019-2024)

9.4 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2019-2030)

10.2 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Company Detail

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction

11.1.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

11.1.5 AstraZeneca Recent Development

11.2 Boehringer Ingelheim International GmbH

11.2.1 Boehringer Ingelheim International GmbH Company Detail

11.2.2 Boehringer Ingelheim International GmbH Business Overview

11.2.3 Boehringer Ingelheim International GmbH Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction

11.2.4 Boehringer Ingelheim International GmbH Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

11.2.5 Boehringer Ingelheim International GmbH Recent Development

11.3 GlaxoSmithKline

11.3.1 GlaxoSmithKline Company Detail

11.3.2 GlaxoSmithKline Business Overview

11.3.3 GlaxoSmithKline Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction

11.3.4 GlaxoSmithKline Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

11.3.5 GlaxoSmithKline Recent Development

11.4 Novartis AG

11.4.1 Novartis AG Company Detail

11.4.2 Novartis AG Business Overview

11.4.3 Novartis AG Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction

11.4.4 Novartis AG Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

11.4.5 Novartis AG Recent Development

11.5 Teva Pharmaceutical Industries

11.5.1 Teva Pharmaceutical Industries Company Detail

11.5.2 Teva Pharmaceutical Industries Business Overview

11.5.3 Teva Pharmaceutical Industries Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction

11.5.4 Teva Pharmaceutical Industries Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

11.5.5 Teva Pharmaceutical Industries Recent Development

11.6 Sunovion Pharmaceuticals

11.6.1 Sunovion Pharmaceuticals Company Detail

11.6.2 Sunovion Pharmaceuticals Business Overview

11.6.3 Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction

11.6.4 Sunovion Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

11.6.5 Sunovion Pharmaceuticals Recent Development

11.7 CHIESI Farmaceutici

11.7.1 CHIESI Farmaceutici Company Detail

11.7.2 CHIESI Farmaceutici Business Overview

11.7.3 CHIESI Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction

11.7.4 CHIESI Farmaceutici Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

11.7.5 CHIESI Farmaceutici Recent Development

11.8 Orion Corporation

11.8.1 Orion Corporation Company Detail

11.8.2 Orion Corporation Business Overview

11.8.3 Orion Corporation Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction

11.8.4 Orion Corporation Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

11.8.5 Orion Corporation Recent Development

11.9 Mylan

11.9.1 Mylan Company Detail

11.9.2 Mylan Business Overview

11.9.3 Mylan Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction

11.9.4 Mylan Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

11.9.5 Mylan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Astrazeneca plc

Boehringer Ingelheim International GmbH

GlaxoSmithKline PLC

Novartis

Teva Pharmaceutical Industries

Sunovion Pharmaceuticals

Chiesi Farmaceutici

Orion Corporation

Mylan NV

List of Tables

Table 1. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Corticosteroids

Table 3. Key Players of Phosphodiesterase Type 4 Inhibitors

Table 4. Key Players of Bronchodilators

Table 5. Key Players of Others

Table 6. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Region (2019-2024)

Table 10. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Region (2025-2030)

Table 12. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Trends

Table 13. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Drivers

Table 14. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Challenges

Table 15. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Restraints

Table 16. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Players (2019-2024)

Table 18. Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment as of 2023)

Table 19. Ranking of Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Solution and Service

Table 23. Date of Enter into Chronic Obstructive Pulmonary Disease (COPD) Treatment Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Type (2019-2024)

Table 27. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Type (2025-2030)

Table 29. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Application (2019-2024)

Table 31. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Application (2025-2030)

Table 33. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 48. AstraZeneca Company Detail

Table 49. AstraZeneca Business Overview

Table 50. AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Treatment Product

Table 51. AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024) & (US$ Million)

Table 52. AstraZeneca Recent Development

Table 53. Boehringer Ingelheim International GmbH Company Detail

Table 54. Boehringer Ingelheim International GmbH Business Overview

Table 55. Boehringer Ingelheim International GmbH Chronic Obstructive Pulmonary Disease (COPD) Treatment Product

Table 56. Boehringer Ingelheim International GmbH Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024) & (US$ Million)

Table 57. Boehringer Ingelheim International GmbH Recent Development

Table 58. GlaxoSmithKline Company Detail

Table 59. GlaxoSmithKline Business Overview

Table 60. GlaxoSmithKline Chronic Obstructive Pulmonary Disease (COPD) Treatment Product

Table 61. GlaxoSmithKline Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024) & (US$ Million)

Table 62. GlaxoSmithKline Recent Development

Table 63. Novartis AG Company Detail

Table 64. Novartis AG Business Overview

Table 65. Novartis AG Chronic Obstructive Pulmonary Disease (COPD) Treatment Product

Table 66. Novartis AG Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024) & (US$ Million)

Table 67. Novartis AG Recent Development

Table 68. Teva Pharmaceutical Industries Company Detail

Table 69. Teva Pharmaceutical Industries Business Overview

Table 70. Teva Pharmaceutical Industries Chronic Obstructive Pulmonary Disease (COPD) Treatment Product

Table 71. Teva Pharmaceutical Industries Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024) & (US$ Million)

Table 72. Teva Pharmaceutical Industries Recent Development

Table 73. Sunovion Pharmaceuticals Company Detail

Table 74. Sunovion Pharmaceuticals Business Overview

Table 75. Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Treatment Product

Table 76. Sunovion Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024) & (US$ Million)

Table 77. Sunovion Pharmaceuticals Recent Development

Table 78. CHIESI Farmaceutici Company Detail

Table 79. CHIESI Farmaceutici Business Overview

Table 80. CHIESI Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Treatment Product

Table 81. CHIESI Farmaceutici Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024) & (US$ Million)

Table 82. CHIESI Farmaceutici Recent Development

Table 83. Orion Corporation Company Detail

Table 84. Orion Corporation Business Overview

Table 85. Orion Corporation Chronic Obstructive Pulmonary Disease (COPD) Treatment Product

Table 86. Orion Corporation Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024) & (US$ Million)

Table 87. Orion Corporation Recent Development

Table 88. Mylan Company Detail

Table 89. Mylan Business Overview

Table 90. Mylan Chronic Obstructive Pulmonary Disease (COPD) Treatment Product

Table 91. Mylan Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024) & (US$ Million)

Table 92. Mylan Recent Development

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type: 2023 VS 2030

Figure 3. Corticosteroids Features

Figure 4. Phosphodiesterase Type 4 Inhibitors Features

Figure 5. Bronchodilators Features

Figure 6. Others Features

Figure 7. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application: 2023 VS 2030

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Retail Pharmacies Case Studies

Figure 12. Other Case Studies

Figure 13. Chronic Obstructive Pulmonary Disease (COPD) Treatment Report Years Considered

Figure 14. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Region: 2023 VS 2030

Figure 17. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Players in 2023

Figure 18. Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue in 2023

Figure 20. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Country (2019-2030)

Figure 22. United States Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Country (2019-2030)

Figure 26. Germany Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Region (2019-2030)

Figure 34. China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Country (2019-2030)

Figure 42. Mexico Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Country (2019-2030)

Figure 46. Turkey Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. AstraZeneca Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

Figure 49. Boehringer Ingelheim International GmbH Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

Figure 50. GlaxoSmithKline Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

Figure 51. Novartis AG Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

Figure 52. Teva Pharmaceutical Industries Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

Figure 53. Sunovion Pharmaceuticals Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

Figure 54. CHIESI Farmaceutici Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

Figure 55. Orion Corporation Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

Figure 56. Mylan Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2019-2024)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Airway Clearance Vest Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-8C14541

Thu Jul 25 00:00:00 UTC 2024

Add to Cart

Global Nitric Oxide Asthma Testing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-9B6080

Fri Jul 12 00:00:00 UTC 2024

Add to Cart

Global Disposable Nasopharyngeal Airway Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-4S12884

Mon Jun 24 00:00:00 UTC 2024

Add to Cart

Global Inhalation Device Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-8B12528

Mon Jun 24 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions